COVID-19 and Diabetes Mellitus: The Mechanisms of Potentially Fatal Comorbidity

Main Article Content

Garza-Cruz Brenda Rocio
Trejo-García Ayde Lizbeth
López-Campos Fátima Elizabeth
Armenta-Velázquez Victoria del Rosario
Gómez-García Karla Aranzazú
Zepeda-Torres José Maria
López-Romero Carlos Arturo
Osuna-Guitierez Felix

Abstract

It's known that Diabetes Mellitus (DM) can be a risky disease, full of complications if it's not controlled properly. These complications, along with the coronavirus disease 2019 (COVID-19) can be lethal due to suppression of innate and humoral immune functions, the hyperglycemic state increases the virulence of pathogens and reduces the production of interleukin in response to infections, which could result in an aggravation of pneumonia. Elevated blood glucose levels can directly elevate airway glucose concentrations, resulting in a higher viral load and these become more viral load and become riskier, it is also important to highlight the importance of ACE2 pulmonary disease because it causes cellular damage and rapid disease progression. It’s because of these mechanisms that DM is related to obesity, coagulopathies, thrombotic events, diabetic ketoacidosis, among others. It is necessary to have proper control of both diseases to improve the patient's quality of life and avoid a  poor prognosis. It is necessary to have proper control of both diseases to improve life quality and avoid a poor prognosis. The patient can rely on good nutritional education, diet, exercise, and adequate glucose to keep control of the disease.

Article Details

How to Cite
Rocio, G.-C. B. ., Lizbeth, T.-G. A. ., López-Campos Fátima Elizabeth, Armenta-Velázquez Victoria del Rosario, Gómez-García Karla Aranzazú, Zepeda-Torres José Maria, López-Romero Carlos Arturo, & Osuna-Guitierez Felix. (2022). COVID-19 and Diabetes Mellitus: The Mechanisms of Potentially Fatal Comorbidity. International Journal of Medical Science and Clinical Research Studies, 2(01), 40–44. https://doi.org/10.47191/ijmscrs/v2-i1-07
Section
Articles

References

I. Seshadri Reddy, Varikasuvua, Naveen Duttb, Balachandar Thangappazhamc, Saurabh Varshneyda. (2020). Diabetes and COVID-19: A pooled analysis. Related to disease severity and mortality. Primary Care Diabetes, 20, 32-35. Doi: 10.1016 /j.pcd. 2020.08.015

II. Azar, W.S., Njeim, R., Fares, A.S., Azar, N.S., Azar, S.T., El Sayed, M., Eid, A.A. (2020). COVID-19 and diabetes mellitus: how one pandemic worsens the other. Endocrine and Metabolic Disorders, 21, 451-463. Doi: 10.1007/s11154-020-09573-6

III. In-Kyung Jeong, Kun Ho Yoon, Moon Kyu Lee. (2020). Diabetes and COVID-19: Global and regional perspectives. 28/10/2020, from International Diabetes Federation

Doi:10.1016/j.diabres.2020.108303Website:https://www.sciencedirect.com/scien ce/article/pii/S0168822720305556

IV. Singh AK, Gupta R, Ghosh A, Misra A. Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations. Diabetes Metab Syndr. 2020 Jul-Aug;14(4):303-310. doi: 10.1016/j.dsx.2020.04.004. Epub April 9 , 2020.

V. Pal R, Bhadada SK. COVID-19 and diabetes mellitus: An unholy interaction of two pandemics. Diabetes Metab Syndr. 2020 Jul-Aug;14(4):513-517. doi: 10.1016/j.dsx.2020.04.049. epub 2020 May 6. PMID: 32388331; PMCID: PMC72028379

VI. S. Cuschieri, S. Crach. (2020). COVID-19 and diabetes: The why, the what, and the how. and the how. Journal of Diabetes and Its Complications, 34, 1056-8727. 2020, October 20, From ELSEVIER Database. Doi:10.1016/j.jdiacomp.2020.107637

VII. S.K. Singh a, Rujul Jain a, Shipra Singh. (2020). Vitamin D deficiency in patients with diabetes and COVID- 19 infection. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 14, 1033-135. Doi:10.1016/j.dsx.2020.06.07

VIII. Marazuela, M., Giustina, A., Puig Domingo, M. (2020). Endocrinology and Metabolic and Endocrinology of the COVID-19 pandemic. Endocrine and Metabolic Disorders, 21, 495-507. Doi:10.1007/s11154-020-09569-2

IX. R Desai, S. Singh, T. Parekh, S. Sachdeva, R. Sachadeva, G. Kumar. (2020). COVID-19 and diabetes mellitus: A need for caution in elderly patients from conjoint analysis. Diabetes & Metabolic Syndrome: Clinical Research &Reviews, 14, 683-685. 2020, October 20, From ELSEVIER Database. Doi.org/10.1016/j.dsx.2020.05.02

X. Giuseppe Pugliese, Martina Vitale1,2 - Veronica Resi, Emanuela Orsi. (2020). Is diabetes mellitus a risk factor for Coronavirus disease 19 (COVID-19)?28/10/2020, from Springer Nature Website:

https://moh-it.pure.elsevier.com/en/publications/is-diabetes-mellitus-a-risk-facto r-for-coronavirus-disease-19-cov Doi:10.1007/s00592-020-01586-6

XI. S. Melmed, S. Polonsky, H. Kronenberg, R. Larsen. (2017). Williams Treatise on Endocrinology 13th Edition. English: ELSEVIER.

XII. McGraw-Hill Interamericana, Harrison Principles of Internal Medicine 19 th edition, 2975. 2. Fontaine, O: 2016.

XIII. Baranski, J. McGill, J. Silverstein. (2019). WASHINGTON HANDBOOK OF CLINICAL SPECIALTIES ENDOCRINOLOGY (4TH ED.). Barcelona: LIPPINCOTT WILLIAMS AND WILKINS. WOLTERS KLUWER HEALTH